Current Events Articles

AZ Central

Pfizer Q4 net jumps on sale of nutrition business

January 29, 2013

NEW YORK -- Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales, because of a $4.8 billion gain from selling its nutrition business. The world's biggest drugmaker said Tuesday that its net income was $6.32 billion, or 85 cents per share, up from $1.44 billion, or 19 cents per share, a year earlier.

Read entire article on AZ Central
« Previous Article Next Article »

More From Current Events Articles

  • U.S. Consumer Borrowing Rises to Record $2.75T
  • The Week on AdFreak: Nov. 30-Dec. 7, 2012
  • The Adweek, Dec. 10-16
  • Best of Luxury

    Finding the best in luxury can be a daunting task, which is why we've taken it on for you.
    View All Best of Luxury
    THINGS WE LIKE